Skip to Content
Merck

719536

3,3′-Diiodo-L-thyronine (T2) hydrochloride

98% (CP)

Synonym(s):

3,3′-·Diiodo-·4-·(4-·hydroxyphenoxy)·-L-phenylalanine, O-(4-·Hydroxyphenyl)-3-,3′-·diiodo-L-tyrosine, T2

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C15H13I2NO4·HCl
CAS Number:
4604-41-5
Molecular Weight:
561.54
UNSPSC Code:
12352211
PubChem Substance ID:
329763657
NACRES:
NA.24

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

3,3′-Diiodo-L-thyronine (T2) hydrochloride, 98% (CP)

SMILES string

OC1=CC=C(OC2=CC=C(CC(N)C(O)=O)C=C2I)C=C1I.Cl

InChI

1S/C15H13I2NO4/c16-10-7-9(2-3-13(10)19)22-14-4-1-8(5-11(14)17)6-12(18)15(20)21/h1-5,7,12,19H,6,18H2,(H,20,21)/t12-/m0/s1

InChI key

CPCJBZABTUOGNM-LBPRGKRZSA-N

assay

98% (CP)

form

powder

technique(s)

mass spectrometry (MS): suitable

storage temp.

−20°C

Quality Level

200

Related Categories

Packaging

This product may be available from bulk stock and can be packaged on demand. For information on pricing, availability and packaging, please contact Stable Isotopes Customer Service.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MBBF1916
MBBF1917
MBBF1741
MBBF1479
MBBF1142

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Nussana Thitichai et al.
Pharmaceutical development and technology, 24(8), 935-946 (2019-01-18)
The present study examined the cytotoxicity and magnetic resonance imaging (MRI) distribution of cancer-targeted, MRI-visible polymeric micelles that encapsulate doxorubicin (DOX) and superparamagnetic iron oxide (SPIO) and are conjugated with glucose as a targeting ligand. In this study, the micelles
Satoshi Tsutsumi et al.
Surgical and radiologic anatomy : SRA, 41(9), 1045-1051 (2019-07-18)
There has not been a study documenting the distribution of cerebrospinal fluid (CSF) pathways in the anterolateral base of the middle fossa (ALB) and diploe of the pterional region (Pt). The present study aimed to delineate these pathways using magnetic
Paolo Zaffino et al.
Physics in medicine and biology, 64(16), 165008-165008 (2019-07-05)
External-beam radiotherapy followed by high dose rate (HDR) brachytherapy is the standard-of-care for treating gynecologic cancers. The enhanced soft-tissue contrast provided by magnetic resonance imaging (MRI) makes it a valuable imaging modality for diagnosing and treating these cancers. However, in
Kenneth H Mayer et al.
PLoS medicine, 14(11), e1002435-e1002435 (2017-11-15)
VRC01 is an HIV-1 CD4 binding site broadly neutralizing antibody (bnAb) that is active against a broad range of HIV-1 primary isolates in vitro and protects against simian-human immunodeficiency virus (SHIV) when delivered parenterally to nonhuman primates. It has been
Heerajnarain Bulluck et al.
Journal of magnetic resonance imaging : JMRI, 46(3), 877-886 (2017-02-16)
To investigate the performance of T Fifty STEMI patients were prospectively recruited between August 2013 and July 2014 following informed consent. Forty-eight patients completed a 1.5T cardiac magnetic resonance imaging (MRI) with native T The mean age was 59 ± 13 years
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service